• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院到家庭:学术中心的门诊患者的肠外抗菌治疗。

Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center.

机构信息

Division of Infectious Diseases, Section of Hospital Medicine, University of California, Davis Medical Center, Sacramento, CA 95817, USA.

出版信息

Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S220-3. doi: 10.1086/653523.

DOI:10.1086/653523
PMID:20731580
Abstract

The cost of health care in the United States continues to increase as an aging population places increasing demands on institutions providing health care. Moreover, despite increases in the complexity and cost of health care, reimbursement for some services has been reduced or denied. Thus, the current challenge at many hospitals throughout the United States is to deliver high-quality health care while maximizing resource use and reducing costs without compromising clinical outcomes. We describe an answer to the challenge that combines 2 emerging treatment models in an academic setting: hospital-based physicians and outpatient parenteral antimicrobial therapy.

摘要

美国的医疗保健成本持续上升,因为老龄化人口对提供医疗保健的机构提出了越来越高的要求。此外,尽管医疗保健的复杂性和成本不断增加,但某些服务的报销却有所减少或被拒绝。因此,目前美国许多医院面临的挑战是,在不影响临床结果的情况下,提供高质量的医疗保健,同时最大限度地利用资源并降低成本。我们描述了一种在学术环境中结合 2 种新兴治疗模式的应对方案:医院医生和门诊肠外抗菌治疗。

相似文献

1
Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center.医院到家庭:学术中心的门诊患者的肠外抗菌治疗。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S220-3. doi: 10.1086/653523.
2
Outpatient parenteral antimicrobial therapy today.今日门诊患者的肠外抗菌治疗。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S198-208. doi: 10.1086/653520.
3
Update and overview of outpatient parenteral antimicrobial therapy regulations and reimbursement.门诊患者的肠外抗菌药物治疗规范和报销的更新与概述。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S216-9. doi: 10.1086/653522.
4
Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.伦敦一家教学医院门诊及家庭肠外抗菌治疗服务的建立:病例系列研究
J Antimicrob Chemother. 2009 Sep;64(3):630-4. doi: 10.1093/jac/dkp212. Epub 2009 Jun 23.
5
Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy.采用门诊胃肠外抗菌疗法应对耐甲氧西林金黄色葡萄球菌带来的挑战。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S171-5. doi: 10.1086/653517.
6
The unique issues of outpatient parenteral antimicrobial therapy in children and adolescents.儿童和青少年门诊肠外抗菌治疗的独特问题。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S209-15. doi: 10.1086/653521.
7
A comparison of two hospitalist models with traditional care in a community teaching hospital.社区教学医院中两种住院医师模式与传统护理的比较。
Am J Med. 2005 May;118(5):536-43. doi: 10.1016/j.amjmed.2005.01.027.
8
Parenteral therapy in the outpatient or home setting: evidence, evaluation and future prospects.门诊或家庭环境中的肠外治疗:证据、评估与未来前景
J Infect. 2001 Apr;42(3):173-5. doi: 10.1053/jinf.2001.0823.
9
A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.门诊肠外抗生素治疗(OPAT)的成本分析:亚洲视角
Int J Antimicrob Agents. 2009 Jan;33(1):46-51. doi: 10.1016/j.ijantimicag.2008.07.016. Epub 2008 Sep 26.
10
Telemedicine: the future of outpatient therapy?远程医疗:门诊治疗的未来?
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S224-30. doi: 10.1086/653524.

引用本文的文献

1
Quantifying the Time to Administer Outpatient Parenteral Antimicrobial Therapy: A Missed Opportunity to Compensate for the Value of Infectious Diseases.量化门诊肠外抗菌治疗的时间:弥补感染病价值的错失机会。
Clin Infect Dis. 2024 Aug 16;79(2):348-350. doi: 10.1093/cid/ciae262.
2
Taking the route less traveled: on the way to COpAT.走少有人走的路:通往协同自适应放疗(COpAT)之路。
Ther Adv Infect Dis. 2023 Aug 15;10:20499361231192771. doi: 10.1177/20499361231192771. eCollection 2023 Jan-Dec.
3
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.
英国成人及儿童门诊胃肠外抗菌治疗(OPAT)的最新良好实践建议。
JAC Antimicrob Resist. 2019 Aug 26;1(2):dlz026. doi: 10.1093/jacamr/dlz026. eCollection 2019 Sep.
4
Pathway with single-dose long-acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections.单剂长效静脉抗生素治疗途径可减少皮肤感染患者的急诊住院次数。
Acad Emerg Med. 2021 Oct;28(10):1108-1117. doi: 10.1111/acem.14258. Epub 2021 May 5.
5
Perspectives of United States-based Infectious Diseases Physicians on Outpatient Parenteral Antimicrobial Therapy Practice.美国传染病医生对门诊胃肠外抗菌治疗实践的看法。
Open Forum Infect Dis. 2019 Oct 1;6(10). doi: 10.1093/ofid/ofz363.
6
Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review.骨科住院和门诊胃肠外抗菌治疗的成本分析:一项系统文献综述
World J Clin Cases. 2019 Jul 26;7(14):1825-1836. doi: 10.12998/wjcc.v7.i14.1825.
7
Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.一项由传染病专家监督的门诊胃肠外抗生素治疗项目的价值及临床影响
Open Forum Infect Dis. 2016 Oct 19;3(4):ofw193. doi: 10.1093/ofid/ofw193. eCollection 2016 Oct.
8
Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.利奈唑胺治疗中重度 ABSSSI 患者的成本效益分析:一项美国支付者预算影响研究。
J Manag Care Spec Pharm. 2016 Jun;22(6):752-64. doi: 10.18553/jmcp.2016.22.6.752.
9
Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity.在瑞士设立门诊肠外抗菌治疗(OPAT)单元:对运营头18个月的回顾
Eur J Clin Microbiol Infect Dis. 2016 May;35(5):839-45. doi: 10.1007/s10096-016-2606-z. Epub 2016 Feb 17.
10
Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis.奥利万星在接受静脉抗生素治疗的急性细菌性皮肤及皮肤结构感染患者中的应用:美国医院预算影响分析
Clin Drug Investig. 2016 Feb;36(2):157-68. doi: 10.1007/s40261-015-0365-8.